{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:48:02Z","timestamp":1792723682257,"version":"4.5.0"},"reference-count":36,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,7,19]]},"abstract":"<jats:p>Background: Olfactory dysfunction is one of the earliest signs of Alzheimer\u2019s disease (AD), highlighting its potential use as a biomarker for early detection. It has also been linked to progression from mild cognitive impairment (MCI) to dementia. Objective: To study olfactory function and its associations with markers of AD brain pathology in non-demented mutation carriers of an autosomal dominant AD (ADAD) mutation and non-carrier family members. Methods: We analyzed cross-sectional data from 16 non-demented carriers of the Presenilin1 E280A ADAD mutation (mean age [SD]: 40.1 [5.3], and 19 non-carrier family members (mean age [SD]: 36.0 [5.5]) from Colombia, who completed olfactory and cognitive testing and underwent amyloid and tau positron emission tomography (PET) imaging. Results: Worse olfactory identification performance was associated with greater age in mutation carriers (r\u200a=\u200a\u20130.52 p\u200a=\u200a0.037). In carriers, worse olfactory identification performance was related to worse MMSE scores (r\u200a=\u200a0.55, p\u200a=\u200a0.024) and CERAD delayed recall (r\u200a=\u200a0.63, p\u200a=\u200a0.007) and greater cortical amyloid-\u03b2 (r\u200a=\u200a\u20130.53, p\u200a=\u200a0.042) and tau pathology burden (entorhinal: r\u200a=\u200a\u20130.59, p\u200a=\u200a0.016; inferior temporal: r\u200a=\u200a\u20130.52, p\u200a=\u200a0.038). Conclusion: Worse performance on olfactory identification tasks was associated with greater age, a proxy for disease progression in this genetically vulnerable ADAD cohort. In addition, this is the first study to report olfactory dysfunction in ADAD mutation carriers with diagnosis of MCI and its correlation with abnormal accumulation of tau pathology in the entorhinal region. Taken together, our findings suggest that olfactory dysfunction has promise as an early marker of brain pathology and future risk for dementia.<\/jats:p>","DOI":"10.3233\/jad-220075","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T12:39:57Z","timestamp":1654605597000},"page":"721-729","source":"Crossref","is-referenced-by-count":15,"title":["Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"88","author":[{"given":"Liliana","family":"Ramirez-Gomez","sequence":"first","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Albers","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Baena","sequence":"additional","affiliation":[{"name":"Grupo de Neurociencias, Universidad de Antioquia, Medellin, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Vila-Castelar","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"Fox-Fuller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alefiya D.","family":"Albers","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Psychology, Endicott College, Beverly, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[{"name":"Grupo de Neurociencias, Universidad de Antioquia, Medellin, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakeel T.","family":"Quiroz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"Grupo de Neurociencias, Universidad de Antioquia, Medellin, Colombia"},{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220075_ref1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jalz.2014.04.514","article-title":"At the interface of sensory and motor dysfunctions and Alzheimer\u2019s disease","volume":"11","author":"Albers","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220075_ref2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40120-020-00199-z","article-title":"Could early identification of changes in olfactory function be an indicator of preclinical neurodegenerative disease? A systematic review","volume":"9","author":"Winchester","year":"2020","journal-title":"Neurol Ther"},{"key":"10.3233\/JAD-220075_ref3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.24447","article-title":"Olfactory identification deficits and increased mortality in the community","volume":"78","author":"Devanand","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220075_ref4","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1212\/WNL.0000000000006919","article-title":"Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain","volume":"92","author":"Dintica","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-220075_ref5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ana.21910","article-title":"Olfactory epithelium amyloid-\u03b2 and paired helical filament-tau pathology in Alzheimer disease","volume":"67","author":"Arnold","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220075_ref6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.1991.tb00184.x","article-title":"Pathologic changes in the olfactory system in aging and Alzheimer\u2019s disease","volume":"640","author":"Hyman","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-220075_ref7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.2006.099721","article-title":"The relationship between cerebral Alzheimer\u2019s disease pathology and odour identification in old age","volume":"78","author":"Wilson","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220075_ref8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1474-4422(17)30123-0","article-title":"Olfactory dysfunction in neurodegenerative diseases: Is there a common pathological substrate?","volume":"16","author":"Doty","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220075_ref9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.24792","article-title":"Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly","volume":"80","author":"Albers","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220075_ref10","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1212\/WNL.0000000000001614","article-title":"Odor identification and Alzheimer disease biomarkers in clinically normal elderly","volume":"84","author":"Growdon","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-220075_ref11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jalz.2018.05.010","article-title":"Olfactory dysfunction in Alzheimer\u2019s disease\u2013and Lewy body\u2013related cognitive impairment","volume":"14","author":"Yoo","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220075_ref12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","article-title":"Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease","volume":"75","author":"Quiroz","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220075_ref13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-4422(10)70323-9","article-title":"Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer\u2019s disease: A retrospective cohort study","volume":"10","author":"Acosta-Baena","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220075_ref14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.trci.2018.02.002","article-title":"The Alzheimer\u2019s Prevention Initiative Autosomal-Dominant Alzheimer\u2019s Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer\u2019s disease, including a placebo-treated noncarrier cohort","volume":"4","author":"Tariot","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220075_ref15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-220075_ref16","first-page":"655","article-title":"Validity and reliability of the CERAD-Col neuropsychological battery","volume":"45","author":"Aguirre-Acevedo","year":"2007","journal-title":"Rev Neurol"},{"issue":"Suppl 1","key":"10.3233\/JAD-220075_ref17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1041610292001157","article-title":"Functional assessment staging (FAST) in Alzheimer\u2019s disease: Reliability, validity, and ordinality","volume":"4","author":"Sclan","year":"1992","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-220075_ref18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1098-1004(1997)10:3<186::AID-HUMU2>3.0.CO;2-H","article-title":"E280A PS-1 mutation causes Alzheimer\u2019s disease but age of onset is not modified by ApoE alleles","volume":"10","author":"Lendon","year":"1997","journal-title":"Hum Mutat"},{"key":"10.3233\/JAD-220075_ref19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-220075_ref20","first-page":"904","article-title":"Correction for partial volume effects in PET: Principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-220075_ref21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","article-title":"Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data","volume":"92","author":"Greve","year":"2014","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-220075_ref22","doi-asserted-by":"crossref","first-page":"100956","DOI":"10.1016\/j.arr.2019.100956","article-title":"Olfactory dysfunction in the pathophysiological continuum of dementia","volume":"55","author":"Bathini","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-220075_ref23","first-page":"665","article-title":"ppcor: An R package for a fast calculation to semi-partial correlation coefficients","volume":"22","author":"Kim","year":"2015","journal-title":"Commun Stat Appl methods"},{"key":"10.3233\/JAD-220075_ref24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2020.00208","article-title":"Age-related olfactory dysfunction: Epidemiology, pathophysiology, and clinical management","volume":"12","author":"Kondo","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220075_ref25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0197-4580(01)00263-9","article-title":"Olfactory impairment increases as a function of age in persons with Down syndrome","volume":"23","author":"Nijjar","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220075_ref26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/lary.27399","article-title":"Olfactory function in mild cognitive impairment and Alzheimer\u2019s disease: A meta-analysis","volume":"129","author":"Jung","year":"2019","journal-title":"Laryngoscope"},{"key":"10.3233\/JAD-220075_ref27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/bios8020041","article-title":"Olfactory dysfunction as a global biomarker for sniffing out Alzheimer\u2019s disease: A meta-analysis","volume":"8","author":"Kotecha","year":"2018","journal-title":"Biosensors"},{"key":"10.3233\/JAD-220075_ref28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/153331750101600210","article-title":"Inherited Alzheimer\u2019s disease PS-1 olfactory function: A 10-year follow-up study","volume":"16","author":"Nee","year":"2001","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-220075_ref29","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1152\/jn.01036.2010","article-title":"The human brain representation of odor identification","volume":"108","author":"Kjelvik","year":"2012","journal-title":"J Neurophysiol"},{"key":"10.3233\/JAD-220075_ref30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/npp.2009.126","article-title":"The episodic memory system: Neurocircuitry and disorders","volume":"35","author":"Dickerson","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-220075_ref31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.0000000000001132","article-title":"Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community","volume":"84","author":"Devanand","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-220075_ref32","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.neurobiolaging.2008.09.008","article-title":"Olfactory identification deficits and MCI in a multi-ethnic elderly community sample","volume":"31","author":"Devanand","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220075_ref33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/13803395.2016.1253667","article-title":"Association between olfaction and higher cortical functions in Alzheimer\u2019s disease, mild cognitive impairment, and healthy older adults","volume":"39","author":"Ward","year":"2017","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.3233\/JAD-220075_ref34","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.0b013e3181f3db84","article-title":"Olfactory system: Functional organization and involvement in neurodegenerative disease","volume":"75","author":"Benarroch","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-220075_ref35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.dadm.2017.09.001","article-title":"Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography","volume":"9","author":"Risacher","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-220075_ref36","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3233\/JAD-170960","article-title":"Odor identification ability predicts PET amyloid status and memory decline in older adults","volume":"62","author":"Kreisl","year":"2018","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:14Z","timestamp":1777370774000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":36,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-220075","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,19]]}}}